Home | Archives | Products | About | Contact | FAQ |
New User? Sign Up | Sign In
Sec Filings Insider Trading - Longitude Capital Associates L.P.
Select Time period:       google icon google     yahoo icon yahoo!
Send this page to:   blogger icon Blog    digg icon Digg    reddit icon Reddit    facebook icon Facebook    stumble icon Stumble    delicious icon del.icio.us

Enter Stock Ticker Symbol or Cik: SEC Cik Lookup Cik Lookup...

Search By Company or Insider Name: Powered by Google button
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch ==>> What is insider trading>>
Insider Trading Transactions for Longitude Capital Associates L.P.
Historical filings delayed by 6 months. New user? Sign Up for real time data. Existing user? Sign In

Common stock purchase or sale:
Transaction
Date
Reported
Date
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2016-11-22
Sale
2016-11-25
9:08 pm
Corcept Therapeutics Inc CORT Longitude Venture Partners L.P.
Longitude Capital Partners LLC
Tammenoms Bakker Juliet
Longitude Capital Associates L.P.
10% Owner
36,941 $9.344 $345,165 13,802,702
(Direct
Indirect)
View
2016-11-17
Sale
2016-11-21
9:10 pm
Corcept Therapeutics Inc CORT Longitude Venture Partners L.P.
Longitude Capital Partners LLC
Tammenoms Bakker Juliet
Longitude Capital Associates L.P.
10% Owner
544,100 $9.556 $5,199,426 14,026,757
(Direct
Indirect)
View
2016-11-15
Sale
2016-11-17
7:32 pm
Corcept Therapeutics Inc CORT Longitude Venture Partners L.P.
Longitude Capital Associates L.P.
Longitude Capital Partners LLC
Tammenoms Bakker Juliet
10% Owner
174,847 $9.549 $1,669,606 14,362,573
(Direct
Indirect)
View
2015-05-12
Purchase
2015-05-14
4:25 pm
Collegium Pharmaceutical Inc COLL Longitude Capital Partners LLC
Longitude Capital Associates L.P.
Longitude Venture Partners L.P.
Tammenoms Bakker Juliet
Enright Patrick G
10% Owner
200,000 $12 $2,400,000 3,256,572
(Indirect)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
Date
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2016-11-28
Other
2016-11-30
9:52 pm
N/A
N/A
Corcept Therapeutics Inc CORT Longitude Venture Partners L.P.
Longitude Capital Partners LLC
Tammenoms Bakker Juliet
Longitude Capital Associates L.P.
10% Owner
2,941,050 $0 10,834,849
(Direct)
View
2016-11-28
Other
2016-11-30
9:52 pm
N/A
N/A
Corcept Therapeutics Inc CORT Longitude Venture Partners L.P.
Longitude Capital Partners LLC
Tammenoms Bakker Juliet
Longitude Capital Associates L.P.
10% Owner
58,950 $0 10,834,849
(Indirect)
View
2015-05-12
Conversion
2015-05-14
4:25 pm
N/A
N/A
Collegium Pharmaceutical Inc COLL Longitude Capital Partners LLC
Longitude Capital Associates L.P.
Longitude Venture Partners L.P.
Tammenoms Bakker Juliet
Enright Patrick G
10% Owner
3,060,502 $0 3,256,572
(Indirect)
View
2015-05-12
Conversion
2015-05-14
4:25 pm
N/A
N/A
Collegium Pharmaceutical Inc COLL Longitude Capital Partners LLC
Longitude Capital Associates L.P.
Longitude Venture Partners L.P.
Tammenoms Bakker Juliet
Enright Patrick G
10% Owner
61,340 $0 3,256,572
(Indirect)
View
2015-05-12
Conversion
2015-05-14
4:25 pm
N/A
N/A
Collegium Pharmaceutical Inc COLL Longitude Capital Partners LLC
Longitude Capital Associates L.P.
Longitude Venture Partners L.P.
Tammenoms Bakker Juliet
Enright Patrick G
10% Owner
12,837,935 $0 3,256,572
(Indirect)
View
2015-05-12
Conversion
2015-05-14
4:25 pm
N/A
N/A
Collegium Pharmaceutical Inc COLL Longitude Capital Partners LLC
Longitude Capital Associates L.P.
Longitude Venture Partners L.P.
Tammenoms Bakker Juliet
Enright Patrick G
10% Owner
257,303 $0 3,256,572
(Indirect)
View
2015-05-12
Conversion
2015-05-14
4:25 pm
N/A
N/A
Collegium Pharmaceutical Inc COLL Longitude Capital Partners LLC
Longitude Capital Associates L.P.
Longitude Venture Partners L.P.
Tammenoms Bakker Juliet
Enright Patrick G
10% Owner
3,160,905 $0 3,256,572
(Indirect)
View
2015-05-12
Conversion
2015-05-14
4:25 pm
N/A
N/A
Collegium Pharmaceutical Inc COLL Longitude Capital Partners LLC
Longitude Capital Associates L.P.
Longitude Venture Partners L.P.
Tammenoms Bakker Juliet
Enright Patrick G
10% Owner
63,356 $0 3,256,572
(Indirect)
View
2015-05-12
Conversion
2015-05-14
4:25 pm
N/A
N/A
Collegium Pharmaceutical Inc COLL Longitude Capital Partners LLC
Longitude Capital Associates L.P.
Longitude Venture Partners L.P.
Tammenoms Bakker Juliet
Enright Patrick G
10% Owner
5,045,381 $0 3,256,572
(Indirect)
View
2015-05-12
Conversion
2015-05-14
4:25 pm
N/A
N/A
Collegium Pharmaceutical Inc COLL Longitude Capital Partners LLC
Longitude Capital Associates L.P.
Longitude Venture Partners L.P.
Tammenoms Bakker Juliet
Enright Patrick G
10% Owner
101,128 $0 3,256,572
(Indirect)
View
2015-03-30
Exercise
2015-04-01
4:05 pm
N/A
N/A
Corcept Therapeutics Inc CORT Longitude Venture Partners L.P.
Longitude Capital Associates L.P.
Longitude Capital Partners LLC
Tammenoms Bakker Juliet
Director
10% Owner
839,811 $4.05 14,516,932
(Direct)
View
2015-03-30
Exercise
2015-04-01
4:05 pm
N/A
N/A
Corcept Therapeutics Inc CORT Longitude Venture Partners L.P.
Longitude Capital Associates L.P.
Longitude Capital Partners LLC
Tammenoms Bakker Juliet
Director
10% Owner
16,833 $4.05 14,516,932
(Indirect)
View
2015-03-30
Exercise
2015-04-01
4:05 pm
2012-03-29
2015-03-30
Corcept Therapeutics Inc CORT Longitude Venture Partners L.P.
Longitude Capital Associates L.P.
Longitude Capital Partners LLC
Tammenoms Bakker Juliet
Director
10% Owner
839,811 $4.05 14,516,932
(Direct)
View
2015-03-30
Exercise
2015-04-01
4:05 pm
2012-03-29
2015-03-30
Corcept Therapeutics Inc CORT Longitude Venture Partners L.P.
Longitude Capital Associates L.P.
Longitude Capital Partners LLC
Tammenoms Bakker Juliet
Director
10% Owner
16,833 $4.05 14,516,932
(Indirect)
View